Continuous Quality Improvement Cohorts on Advanced Access
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05715151 |
|
Recruitment Status :
Recruiting
First Posted : February 6, 2023
Last Update Posted : February 6, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Primary Health Care | Other: CQI intervention Other: Audit and Feedback | Not Applicable |
SIGNIFICANCE AND PURPOSE: Timely access to primary healthcare is one cornerstone of strong primary healthcare. Across Canada, timely access remains a significant challenge. One of the most highly recommended models around the world to improve timely access is advanced access (AA). Over the last two decades, AA has become increasingly popular in Canada. AA model has been widely promoted by the College of Family Physicians of Canada and several other provincial organizations and professional associations. Some tools to support the implementation of AA to PHC providers and practices have been developed such as workbook by Health Quality Ontario and Doctor of BC. However, those tools are important assets to initiate a reflection to improve, they are often not sufficient. Eight PHC teams interested in improving and expanding the implementation of AA have been coached through several PDSA cycles. However, the personalized support model used is very demanding in terms of capacity and resources. These findings guided the research team in developing and evaluating a Continuous Quality Improvement (CQI) Cohort program on advanced access to support Primary healthcare (PHC) teams.This study aims to develop knowledge on an externally facilitated CQI pan-Canadian cohort program that could potentially be transferred to provincial organizations or professional associations wishing to support clinics in quality improvement projects.
OBJECTIVE: Assess the effectiveness of CQI cohorts on AA outcomes.
QI INTERVENTION PROGRAM: PHC teams will participate in an externally facilitated CQI program focusing on AA. The proposed program consists of cycle of three key activities; 1) Interprofessional reflective sessions and need prioritization, 2) Group mentoring and PDSA Cycles and 3) Cohort cross-learning exchange opportunities.
METHODS: This study will be based on the cluster-controlled trial of a CQI program of PHC teams on AA. 48 PHC teams from Quebec will participate to the externally facilitated CQI cohort intervention. Volunteer clinics from the intervention regions will receive the CQI intervention for 18 months. Intervention clinics will be matched to PHC clinics located in other regions to compose the control group. The match will be based on the clinic level (1 to 10, based on the number of patients registered and services offered. Clinics in the control group will receive an audit on a selection of AA indicators and will be offered the intervention 12 to 18 months following their recruitment. Data collection and analysis will include quantitative data based on a comprehensive assessment of both AA processes and outcomes. These will be measured through a self-reflective survey for PHC team members, EMR data and patients related outcomes questionnaire on access. Qualitative data based on semi-structured interviews with key stakeholders, observations of the CQI activities and analysis of plans of action of documents plan of action will take place.
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 48 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Health Services Research |
| Official Title: | Impact of Externally Facilitated Continuous Quality Improvement Cohorts on Advanced Access to Support Primary Healthcare Teams |
| Actual Study Start Date : | September 21, 2022 |
| Estimated Primary Completion Date : | June 1, 2024 |
| Estimated Study Completion Date : | June 1, 2025 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: CQI intervention
The proposed CQI cohort consists of three activities carried out iteratively until the improvement objectives are achieved.
|
Other: CQI intervention
Activity 1: Reflective sessions and problem prioritisation. Activity 2: PDSA cycles. Activity 3: Group mentoring. |
|
Active Comparator: Audit and feedback
Clinics in the control group will receive feedback on six key AA indicators, patients reported experience about access and selected AA processes.
|
Other: Audit and Feedback
Audit and Feedback on six key AA indicators, patients reported experience about access and selected AA processes. |
- 3rd next available appointment (weekly) [ Time Frame: 18 month ]Delay before the 3rd next available appointment. The 3rd next available appointment is used (rather than the 1st or 2nd) to decrease variation.
- Percent of relational continuity (monthly) [ Time Frame: 18 month ]Total number of medical consultations with a patient's attached family physician (or specialised nurse) out of the total number of consultations with any family physician (or specialised nurse) from the clinic. Evaluates relational continuity between the provider and their registered patients.
- Percent of 48-hour open slots (weekly) [ Time Frame: 18 month ]Proportion of appointments available in the next 48 hours. Provides an overview of the provider's ability to respond to urgent care demands.
- Use of walk-in (monthly) [ Time Frame: 18 month ]Proportion of walk-in visits by registered patients to each professional.
- Proportion of multidisciplinary involvement (monthly) [ Time Frame: 18 month ]Evaluates the proportion of involvement of different types of providers (social workers, nurses, pharmacists, etc.) with registered patients.
- Discontinuity for chronic patients (monthly) [ Time Frame: 18 month ]Proportion of chronic patients without any consultations within the last 12 months.
- 3rd next available appointment (weekly) [ Time Frame: 12 month ]Delay before the 3rd next available appointment. The 3rd next available appointment is used (rather than the 1st or 2nd) to decrease variation.
- Percent of relational continuity (monthly) [ Time Frame: 12 month ]Total number of medical consultations with a patient's attached family physician (or specialised nurse) out of the total number of consultations with any family physician (or specialised nurse) from the clinic. Evaluates relational continuity between the provider and their registered patients.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion criteria:
- Clinics must offer interprofessional care.
- At least 50 % of all team members should accept to take part in the study.
Exclusion criteria:
- Solo Practice Physicians
- Physician-nurse only model
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05715151
| Contact: Elisabeth Martin, Ph.D(c) | 5147799926 | elisabeth.martin@usherbrooke.ca |
Show 18 study locations
| Principal Investigator: | Mylaine Breton, PhD | Université de Sherbrooke |
| Responsible Party: | Mylaine Breton, Associate Professor, Department of Community Health Sciences, Université de Sherbrooke |
| ClinicalTrials.gov Identifier: | NCT05715151 |
| Other Study ID Numbers: |
MP-04-2022-696 |
| First Posted: | February 6, 2023 Key Record Dates |
| Last Update Posted: | February 6, 2023 |
| Last Verified: | February 2023 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Advanced Access Primary Health Care Quality improvement |